Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Land & Improvements (2016 - 2024)

Angiodynamics' Land & Improvements history spans 13 years, with the latest figure at $493000.0 for Q2 2024.

  • For Q2 2024, Land & Improvements changed 0.0% year-over-year to $493000.0; the TTM value through May 2024 reached $493000.0, changed 0.0%, while the annual FY2024 figure was $493000.0, 0.0% changed from the prior year.
  • Land & Improvements reached $493000.0 in Q2 2024 per ANGO's latest filing, roughly flat from $493000.0 in the prior quarter.
  • In the past five years, Land & Improvements ranged from a high of $493000.0 in Q2 2022 to a low of $472000.0 in Q2 2020.
  • Average Land & Improvements over 5 years is $484600.0, with a median of $493000.0 recorded in 2022.
  • Peak YoY movement for Land & Improvements: tumbled 56.42% in 2020, then grew 4.45% in 2022.
  • A 5-year view of Land & Improvements shows it stood at $472000.0 in 2020, then changed by 0.0% to $472000.0 in 2021, then rose by 4.45% to $493000.0 in 2022, then changed by 0.0% to $493000.0 in 2023, then changed by 0.0% to $493000.0 in 2024.
  • Per Business Quant, the three most recent readings for ANGO's Land & Improvements are $493000.0 (Q2 2024), $493000.0 (Q2 2023), and $493000.0 (Q2 2022).